Scantox Denmark ApS

CVR42015768

Core data

Name
Scantox Denmark ApS
Address
Hestehavevej 36A, 4623, Lille Skensved
Founded
Jan 11, 2021
33 / 32
Locations (P-units)
1View locations
Website
https://scantox.com/
Branch
Ikke-finansielle holdingselskaber (642120)

Keep track of Scantox Denmark ApS

Get an email when we detect changes to financial reports, ownership or management. Save yourself checking the company again.
Free account

Financials

Reporting period
2025EUR
Revenue
55,522,000
Profit before tax
-8,647,000
Net income
-6,194,000
Total assets
164,270,000
Equity
49,109,000
Avg. employees
396
2021–2025

Unlock financial history

Datapublica Risk Score

Locked
Assesses the risk of financial distress using the company’s accounts, history, and connections.
Company score
0 · Low100 · High

What goes into the assessment

  • Financials

  • Accounts and history

  • Owners and management

  • Company and connections

Standard: Score and risk bandPro: Also a detailed explanation of the factors

Contact

No contact details have been registered for this company.

Gazelle

Loading gazelle status…

Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.

People

Jens BagerRoles
Board
TitlesFORMAND
Nicholas Povl Zilstorff HoogeRoles
Board
TitlesBESTYRELSESMEDLEM
Emil Staal BerganderRoles
Management
TitlesDIREKTØR
Jeanet Løgsted NielsenRoles
Management
TitlesDIREKTØR

Auditor

EY Godkendt RevisionspartnerselskabAuditorChristian CarlsbækRoleState Authorised Public AccountantFromMay 27, 2026
EY Godkendt RevisionspartnerselskabAuditorOle BeckerRoleState Authorised Public AccountantFromMay 27, 2026
Ownership100 %Voting rights100 %FromAug 31, 2023

Child companies

Ownership100 %Voting rights100 %FromJan 19, 2021
Ownership100 %Voting rights100 %FromNov 20, 2023

Ultimate owners

🇸🇪Impilo No 9 AB
Ownership through
66.67–89.99 %

Indirectly owned companies

Calculated through shown level 2–3 paths
MLMC Therapeutics ApS
Ownership through
5–9.99 %